SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-011560
Filing Date
2017-05-23
Accepted
2017-05-23 16:30:45
Documents
3
Period of Report
2017-05-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sbph-8k_20170523.htm 8-K 25931
2 EX-99.1 sbph-ex991_16.htm EX-99.1 24585
3 GRAPHIC g20170523182004770532.jpg GRAPHIC 5029
  Complete submission text file 0001564590-17-011560.txt   58670
Mailing Address 86 SOUTH STREET HOPKINTON MA 01748
Business Address 86 SOUTH STREET HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37718 | Film No.: 17864087
SIC: 2834 Pharmaceutical Preparations